Christopher Orton
Professor of Pharmaceutical Compounding at University of Utah College of Pharmacy- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
Portuguese -
Topline Score
Bio
Credentials
-
USP 797
University of Utah College of PharmacySep, 2015- Oct, 2024 -
Immunization Certification
American Pharmacists AssociationSep, 2014- Oct, 2024 -
Pharmacist
Utah Division of Occupational and Professional LicensingSep, 2017- Oct, 2024 -
Basic Life Support
International CPR InstituteJul, 2015- Oct, 2024 -
Pharmacy Intern
Utah Division of Occupational and Professional LicensingJul, 2013- Oct, 2024
Experience
-
University of Utah College of Pharmacy
-
United States
-
Higher Education
-
1 - 100 Employee
-
Professor of Pharmaceutical Compounding
-
Aug 2021 - Present
-
-
-
Gibsons Pharmacy & Compounding
-
Murray, UT
-
Pharmacist, Owner
-
Jun 2018 - Present
-
-
-
JOLLEYS COMPOUNDING PHARMACY INC
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Staff Pharmacist
-
May 2017 - May 2018
-
-
-
Harmons Grocery
-
United States
-
Retail
-
700 & Above Employee
-
Pharmacy Intern
-
Oct 2013 - Apr 2017
Active role in the input, processing/billing, filling, verification, and patient counseling of all prescriptions. Active role in the input, processing/billing, filling, verification, and patient counseling of all prescriptions.
-
-
-
Covance Laboratories
-
Madison, WI
-
Staff Scientist/Principal Investigator - Department of Drug Metabolism
-
Jul 2009 - Jul 2013
Performed metabolite identification and structure characterization using state of the art, high resolution, liquid chromatography mass spectrometry (LC-MS). Good laboratory practice (GLP) based metabolite profiling of test compounds utilizing high-performance liquid chromatography (HPLC) and radio-chromatography. Provided quantitative LC-MS support for pharmacokinetic/toxicokinetic (PK/TK) studies. Implementing and troubleshooting LC-MS instrumentation and method development. Performed metabolite identification and structure characterization using state of the art, high resolution, liquid chromatography mass spectrometry (LC-MS). Good laboratory practice (GLP) based metabolite profiling of test compounds utilizing high-performance liquid chromatography (HPLC) and radio-chromatography. Provided quantitative LC-MS support for pharmacokinetic/toxicokinetic (PK/TK) studies. Implementing and troubleshooting LC-MS instrumentation and method development.
-
-
-
University of Utah Health
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Postdoctoral Research Fellow - Departments of Pharmacology & Toxicology and Pediatrics
-
Sep 2006 - Jul 2009
Involved in projects comparing metabolism of inhaled glucocorticoids by cytochrome P450 3A enzymes in the lung (metabolite ID, structure elucidation (LC/MS), kinetic parameters (VMAX and KM)). Regulation of P450 3A enzymes in airway cells by inhaled glucocorticoids (qRT-PCR) and subsequent effects on glucocorticoid metabolism and developmental expression of P450 3A enzymes measuring P450 3A expression in airways of pediatric patients Performed preliminary work on a genotyping study (genotyping pediatric asthmatics for P450 3A polymorphisms). Show less
-
-
-
Vanderbilt University
-
United States
-
Higher Education
-
700 & Above Employee
-
Research Assistant - Department of Biochemistry
-
Jul 2003 - Aug 2006
Finding correlations between protein adduction with activation of specific cell signaling events (survival, death, apoptosis, etc.), more specifically activation of c-Jun N-terminal kinase, a member of the mitogen activated cell kinase (MAPK) family of enzymes and activation of apoptotic pathways. Also making chemical comparisons of extents of protein adduction in different cell types by different adducting agents (Michael vs. SN2 mechanism, etc.) Finding correlations between protein adduction with activation of specific cell signaling events (survival, death, apoptosis, etc.), more specifically activation of c-Jun N-terminal kinase, a member of the mitogen activated cell kinase (MAPK) family of enzymes and activation of apoptotic pathways. Also making chemical comparisons of extents of protein adduction in different cell types by different adducting agents (Michael vs. SN2 mechanism, etc.)
-
-
-
University of Arizona
-
United States
-
Higher Education
-
700 & Above Employee
-
Graduate Student Researcher - Department of Pharmacology & Toxicology
-
Jul 2001 - Jul 2003
Identifying protein adducts on glutathione S-transferase (GST) P1-1 using model Michael and SN2 mechanism based compounds by LC-MS techniques. Developed methodology to simultaneously compare multiple adduction sites on the same protein using N-terminal peptide labeling with phenyl isocyanate and quantitative LC-MS to calculate rate constant (k) for each site with different modifying chemicals. Identifying protein adducts on glutathione S-transferase (GST) P1-1 using model Michael and SN2 mechanism based compounds by LC-MS techniques. Developed methodology to simultaneously compare multiple adduction sites on the same protein using N-terminal peptide labeling with phenyl isocyanate and quantitative LC-MS to calculate rate constant (k) for each site with different modifying chemicals.
-
-
Education
-
University of Utah
Doctor of Pharmacy (PharmD) -
University of Arizona
Doctor of Philosophy (Ph.D.), Pharmacology and Toxicology -
Southern Utah University
Bachelor of Arts (B.A.), Biochemistry